• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CareMax to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

    9/6/23 6:55:00 AM ET
    $CMAX
    Hospital/Nursing Management
    Health Care
    Get the next $CMAX alert in real time by email

    CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, announced today that Chief Executive Officer, Carlos de Solo, and Chief Financial Officer, Kevin Wirges, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023, at 7:30 am Eastern Time.

    A live webcast and replay of the event will be available on CareMax's investor relations website at ir.caremax.com.

    About CareMax

    Founded in 2011, CareMax is a value-based care delivery system that utilizes a proprietary technology-enabled platform and multi-specialty, whole person health model to deliver comprehensive, preventative and coordinated care for its members. With over 200,000 Medicare Value-Based Care Members across 10 states, and fully integrated, Five-Star Quality rated health and wellness centers, CareMax is redefining healthcare across the country by reducing costs, improving overall outcomes and promoting health equity for seniors. Learn more at www.caremax.com.

    Forward Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth, strategy and financial performance. Words such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "envision," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "pro forma," "project," "seek," "should," "target," or "will," or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. These forward-looking statements reflect the Company's expectations, plans or forecasts of future events and views as of the date of this press release. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.

    Important risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, the Company's ability to integrate acquired businesses, including the ability to implement business plans, forecasts, and other expectations after the completion of the Steward transaction; the failure to realize anticipated benefits of the Steward transaction or to realize estimated pro forma results and underlying assumptions; the impact of COVID-19 or any variant thereof or any other pandemic or epidemic on the Company's business and results of operation; the Company's ability to attract new patients; the availability of sites for de novo centers and the costs of opening such de novo centers; changes in market or industry conditions, regulatory environment, competitive conditions, and receptivity to the Company's services; the Company's ability to continue its growth, including in new markets; changes in laws and regulations applicable to the Company's business, in particular with respect to Medicare Advantage and Medicaid; the Company's ability to maintain its relationships with health plans and other key payers; any delay, modification or cancellation of government contracts; the Company's future capital requirements and sources and uses of cash, including funds to satisfy its liquidity needs and the Company's ability to comply with the covenants under the agreements governing its indebtedness; the Company's ability to address the material weakness in its internal control over financial reporting; the Company's ability to recruit and retain qualified team members and independent physicians; risks related to future acquisitions; the Company's ability to develop and maintain proper and effective internal control over financial reporting and the impact of any prior period developments. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in the Company's reports filed with the SEC. All information provided in this press release is as of the date hereof, and the Company undertakes no duty to update or revise this information unless required by law, and forward-looking statements should not be relied upon as representing the Company's assessments as of any date subsequent to the date of this press release.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230906984294/en/

    Get the next $CMAX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CMAX

    DatePrice TargetRatingAnalyst
    2/26/2024$1.50 → $7.50Buy → Hold
    Jefferies
    11/17/2023$5.00 → $1.00Buy → Neutral
    UBS
    11/10/2023$3.00 → $2.00Overweight → Neutral
    Piper Sandler
    3/17/2023$7.00 → $4.00Outperform → Market Perform
    TD Cowen
    9/7/2022$7.50Hold
    Truist
    1/7/2022$14.00Buy
    UBS
    10/20/2021$15.00Buy
    Jefferies
    9/13/2021$14.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CMAX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CareMax downgraded by Jefferies with a new price target

      Jefferies downgraded CareMax from Buy to Hold and set a new price target of $7.50 from $1.50 previously

      2/26/24 7:26:58 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax downgraded by UBS with a new price target

      UBS downgraded CareMax from Buy to Neutral and set a new price target of $1.00 from $5.00 previously

      11/17/23 7:26:57 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded CareMax from Overweight to Neutral and set a new price target of $2.00 from $3.00 previously

      11/10/23 7:33:59 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    SEC Filings

    See more
    • CareMax Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - CareMax, Inc. (0001813914) (Filer)

      11/25/24 6:35:08 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update, Financial Statements and Exhibits

      8-K - CareMax, Inc. (0001813914) (Filer)

      11/18/24 6:55:10 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • SEC Form NT 10-Q filed by CareMax Inc.

      NT 10-Q - CareMax, Inc. (0001813914) (Filer)

      11/13/24 4:56:07 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CareMax Enters Into Agreement to Sell Core Centers' Assets

      ClareMedica Health Partners to become "Stalking Horse" Bidder to Acquire CareMax's Core Centers' Assets CareMax, Inc. (NASDAQ:CMAX, CMAXW)) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced that it has entered into a "stalking horse" purchase agreement with ClareMedica Health Partners ("ClareMedica"), a leader in value-based primary care serving patients in Florida, pursuant to which ClareMedica will acquire CareMax's core centers' assets including a vast majority of CareMax's operating clinics (the "Core Centers' Assets"). The transaction will be implemented pursuant to a previously announced prearranged chapter 11 plan support

      11/25/24 6:30:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Reaches Agreements to Sell Management Services Organization and Core Centers' Assets

      Revere Medical Enters into Agreement to Acquire CareMax's Management Services Organization Agreement in Principle Reached with "Stalking Horse" for Core Centers' Assets Sale Transactions to be Implemented Through an Expedited Prearranged Chapter 11 Plan Supported by 100% of CareMax's Secured Lenders CareMax Secures $30.5 Million in Debtor in Possession Financing to Support Operations and Continuing Provision of Healthcare Services Throughout Restructuring Process CareMax, Inc. (NASDAQ:CMAX, CMAXW)) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced it has entered into an agreement to sell its management services organization

      11/17/24 6:17:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Reports Second Quarter 2024 Results

      Second Quarter Medicare Advantage Membership of 104,000, up 1% year-over-year Second Quarter Total Revenue of $198.6 million, down 12% year-over-year CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the second quarter ended June 30, 2024. "Although our medical expense ratio continued to run higher than target levels, we were able to manage toward another quarter of sequential improvement in MER in the second quarter, and we continued to make progress against our clinical initiatives," said Carlos de Solo, Chief Executive Officer. Mr. de Solo continued, "Additiona

      8/9/24 5:30:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care